Le Lézard
Classified in: Health
Subjects: HSP, POL, AVO, DEI

Statement of the National Alliance for Hispanic Health on Introduction of Personal Care Products Safety Act


WASHINGTON, June 17, 2021 /PRNewswire/ -- "Consumers want to know that if it's on the shelf or in their online cart that the shampoo, make-up, after shave or other personal care products they buy are safe," said Jane L. Delgado, PhD, MS, President and CEO of the National Alliance for Hispanic Health (the Alliance), the nation's leading Hispanic health advocacy group.

"The Alliance is proud to support the Personal Care Products Safety Act introduced today by Senators Susan Collins (R-ME) and Dianne Feinstein (D-CA) to protect consumers and strengthen FDA's oversight of cosmetics and other personal care products. Everyday millions of men and women use cosmetics and personal care products like shampoo and lotion and assume that they are safe. It is shocking that the FDA does not have adequate authority to ensure that the ingredients in these products that American families use daily are safe, nor does FDA have adequate authority to recall these products if they are found to be dangerous."

"This legislation, if enacted, would represent the first new consumer protections on cosmetics and personal care products in 83 years. It is action long overdue and we look forward to the bill becoming law," concluded Dr. Delgado.

About the National Alliance for Hispanic Health (The Alliance)
The Alliance is the nation's foremost science-based source of information and trusted advocate for the health of Hispanics in the United States with a mission to achieve the best health for all. For more information visit us at www.healthyamericas.org

SOURCE National Alliance for Hispanic Health


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: